ITC Report on TRIPS COVID IP Waiver Extension Plays it Safe
The U.S. International Trade Commission (ITC) released a sprawling report on Tuesday analyzing market dynamics surrounding the question of whether to extend the waiver of IP rights for COVID-19 technologies under the TRIPS Agreement to diagnostics and therapeutics.